Literature DB >> 12754741

Prognostic significance of BRCA1 expression in sporadic breast carcinomas.

H Lambie1, A Miremadi, S E Pinder, J A Bell, P Wencyk, E C Paish, R D Macmillan, I O Ellis.   

Abstract

BRCA1 is a tumour suppresser gene frequently mutated in familial breast cancer and thought to influence the progression of sporadic breast cancer. Decreased BRCA1 mRNA and protein expression has been identified in breast cancer cell lines and sporadic breast tumours. Here the prognostic significance of reduced BRCA1 protein expression is investigated in primary operable breast cancer. Immunohistochemical analysis was used to determine the level of BRCA1 protein expression in 100 breast cancers. BRCA1 expression was compared with known prognostic factors and survival to investigate its prognostic significance. BRCA1 nuclear expression was reduced by varying amounts in breast carcinomas. A progressive loss of BRCA1 expression correlated well with higher histological grade (p = 0.002) and an excess of medullary/atypical medullary/grade 3 ductal carcinomas (p = 0.0001). When adjusted for grade, patients with loss of BRCA1 expression had a significantly longer disease-free survival time. Loss of BRCA1 expression associated with high-grade breast tumours suggests that BRCA1 may play an important role in the pathogenesis of sporadic breast cancer. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12754741     DOI: 10.1002/path.1348

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  20 in total

1.  BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression.

Authors:  Amanjit Bal; Sangeeta Verma; Kusum Joshi; Anuj Singla; Ravi Thakur; Sunil Arora; Gurpreet Singh
Journal:  Virchows Arch       Date:  2012-07-21       Impact factor: 4.064

2.  Prognostic significance of BRCA1 expression in gastric cancer.

Authors:  Wenjiao Chen; Jian Wang; Xiao Li; Jingying Li; Li Zhou; Tianzhu Qiu; Meiling Zhang; Ping Liu
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

3.  A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer.

Authors:  Monika Graeser; Afshan McCarthy; Christopher J Lord; Kay Savage; Margaret Hills; Janine Salter; Nicholas Orr; Marina Parton; Ian E Smith; Jorge S Reis-Filho; Mitch Dowsett; Alan Ashworth; Nicholas C Turner
Journal:  Clin Cancer Res       Date:  2010-08-27       Impact factor: 12.531

Review 4.  BRCA1 Mutation: A Predictive Marker for Radiation Therapy?

Authors:  Charlene Kan; Junran Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-01       Impact factor: 7.038

5.  Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours.

Authors:  Roy Milner; Helen Wombwell; Sonia Eckersley; Donna Barnes; Juli Warwicker; Erica Van Dorp; Rachel Rowlinson; Simon Dearden; Glen Hughes; Chris Harbron; Bob Wellings; Darren Hodgson; Chris Womack; Neil Gray; Alan Lau; Mark J O'Connor; Catherine Marsden; Alexander J Kvist
Journal:  Virchows Arch       Date:  2013-01-25       Impact factor: 4.064

6.  The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation.

Authors:  Yunzhe Lu; Jiezhi Li; Dongmei Cheng; Balaji Parameswaran; Shaohua Zhang; Zefei Jiang; P Renee Yew; Junmin Peng; Qinong Ye; Yanfen Hu
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

7.  Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer.

Authors:  Konrad H Stopsack; Travis Gerke; Piotr Zareba; Andreas Pettersson; Dipanjan Chowdhury; Ericka M Ebot; Richard Flavin; Stephen Finn; Philip W Kantoff; Meir J Stampfer; Massimo Loda; Michelangelo Fiorentino; Lorelei A Mucci
Journal:  Carcinogenesis       Date:  2020-07-14       Impact factor: 4.944

8.  Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer.

Authors:  Sylvie M Noordermeer; Marloes Wennemers; Saskia M Bergevoet; Adrian van der Heijden; Evelyn Tönnissen; Fred C G J Sweep; Joop H Jansen; Paul N Span; Bert A van der Reijden
Journal:  Breast Cancer Res Treat       Date:  2012-06-16       Impact factor: 4.872

9.  The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells.

Authors:  Johanne I Weberpals; Anna M O'Brien; Nima Niknejad; Kyla D Garbuio; Katherine V Clark-Knowles; Jim Dimitroulakos
Journal:  Cancer Cell Int       Date:  2011-08-19       Impact factor: 5.722

10.  BRCA1 Protein Expression Level and CD44(+)Phenotype in Breast Cancer Patients.

Authors:  Zahra Madjd; Adel Karimi; Saadat Molanae; Mohsen Asadi-Lari
Journal:  Cell J       Date:  2011-09-23       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.